人工智能能否降低儿童PET/CT剂量?机遇、证据与注意事项
本文综述了人工智能用于儿童PET/CT剂量优化的路径,包括低计数PET去噪、图像增强、全计数合成、重建整合AI、低剂量CT重建、合成CT、无CT衰减/散射校正、运动校正和自动化质控等。最直接的机遇是低计数PET增强和AI辅助CT降剂量,但AI增强的低剂量PET/CT必须在小病灶检测、定量准确性、分型稳定性、通用性和失败模式等方面验证;视觉改善不足以作为终点。
要点
- 低计数PET增强与AI辅助CT降剂量是儿童PET/CT最直接的降剂量机遇。
- 合成CT与无CT校正可在不需诊断CT时减少或消除衰减校正CT。
- AI降剂量须验证小病灶检测、定量准确性和分型稳定性,视觉改善不是终点。
核心结论
- AI可能降低儿童PET/CT剂量,但仅在能保持临床价值且置于受治理的儿科专用优化框架内时才成立。
研究设计与样本
- 本文为综述,考察AI用于儿童PET/CT剂量优化的路径,包括低计数PET去噪、图像增强、全计数合成、重建整合AI、低剂量CT重建、合成CT、无CT衰减/散射校正、运动校正、自动化质控和患者特异性协议选择等。
主要发现
- 最直接的机遇是低计数PET增强和AI支持的CT降剂量;合成CT与无CT校正可在不需诊断CT的特定场景中减少或消除衰减校正CT。
- 间接AI方法如运动风险降低、质控系统和智能体工作流支持可通过提高首次成像成功率、避免重复采集和匹配协议与临床问题来降剂量。
- 须区分视觉美观图像与诊断图像,视觉图像改善是不充分的终点。
关键数值与推荐
- AI增强的低剂量PET/CT须验证小病灶检测、定量准确性、反应分型稳定性、扫描仪与示踪剂通用性、失败模式和前瞻性临床安全性。
临床怎么用
- 在儿科专用优化框架内使用AI降剂量工具,优先验证诊断性能而非视觉改善,并关注社会、伦理和法律因素以避免扩大 disparities。
局限性
- AI工具存在扩大 disparities 的潜在风险,且需在受治理框架内验证失败模式和前瞻性临床安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Artificial intelligence (AI) has emerged as a potential enabling technology for lower-dose paediatric PET/CT, but its value depends on whether dose reduction can be achieved without compromising diagnostic accuracy, lesion detectability, quantitative reliability or clinical confidence. This review examines AI-enabled pathways for paediatric PET/CT dose optimisation, including low-count PET denoising, image enhancement, full-count synthesis, reconstruction-integrated AI, low-dose CT reconstruction, synthetic CT, CT-free attenuation/scatter correction, motion correction, automated quality control, patient-specific protocol selection and reduction of unnecessary or repeat imaging. The strongest direct opportunities are low-count PET enhancement and AI-supported CT dose reduction, while synthetic CT and CT-free correction may reduce or eliminate attenuation-correction CT in selected settings where diagnostic CT is not required. Indirect AI approaches, including motion-risk reduction, quality-control systems and agentic workflow support, may reduce dose by improving first-time-right imaging, avoiding repeat acquisition and matching protocols to the clinical question. It is important to differentiate between visually aesthetic images and diagnostic images, in other words, visual image improvement is an inadequate endpoint. AI-enhanced lower-dose PET/CT must be validated for small-lesion detection, quantitative accuracy, response-classification stability, scanner and tracer generalisability, failure modes and prospective clinical safety. Social, ethical and legal considerations are also central, because AI tools have the potential to widen disparities. AI may make paediatric PET/CT lower dose, but only when it preserves clinical value within a governed, paediatric-specific optimisation framework.
引用
- Currie GM, Rohren EM. Can AI Make Paediatric PET/CT Lower Dose? Opportunities, Evidence and Cautions. Semin Nucl Med. 2026. PMID: 42481262. doi:10.1053/j.semnuclmed.2026.07.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。